DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Takegawa N, Nonagase Y, Yonesaka K. et al.
DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
Int J Cancer 2017;
141: 1682-1689
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.